| Product Code: ETC6211365 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import trend of rare disease treatment in Austria during 2020-2024 showed a Compound Annual Growth Rate (CAGR) of 2.85%. In 2023-2024, the year-on-year growth rate was 3.71%, indicating a steady increase in imports over the period.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Rare Disease Treatment Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Rare Disease Treatment Market Revenues & Volume, 2022 & 2032F |
3.3 Austria Rare Disease Treatment Market - Industry Life Cycle |
3.4 Austria Rare Disease Treatment Market - Porter's Five Forces |
3.5 Austria Rare Disease Treatment Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Austria Rare Disease Treatment Market Revenues & Volume Share, By Therapeutic Area, 2022 & 2032F |
3.7 Austria Rare Disease Treatment Market Revenues & Volume Share, By Administration, 2022 & 2032F |
4 Austria Rare Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of rare diseases in Austria |
4.2.2 Government initiatives and funding to support rare disease treatment |
4.2.3 Advances in medical research leading to the development of new treatments |
4.3 Market Restraints |
4.3.1 High cost of rare disease treatments leading to affordability issues |
4.3.2 Limited availability of specialized healthcare professionals for rare diseases |
4.3.3 Regulatory challenges in the approval and market access of rare disease treatments |
5 Austria Rare Disease Treatment Market Trends |
6 Austria Rare Disease Treatment Market, By Types |
6.1 Austria Rare Disease Treatment Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Austria Rare Disease Treatment Market Revenues & Volume, By Drug Type, 2022-2032F |
6.1.3 Austria Rare Disease Treatment Market Revenues & Volume, By Biologics, 2022-2032F |
6.1.4 Austria Rare Disease Treatment Market Revenues & Volume, By Non-Biologics, 2022-2032F |
6.2 Austria Rare Disease Treatment Market, By Therapeutic Area |
6.2.1 Overview and Analysis |
6.2.2 Austria Rare Disease Treatment Market Revenues & Volume, By Genetic Diseases, 2022-2032F |
6.2.3 Austria Rare Disease Treatment Market Revenues & Volume, By Neurological Diseases, 2022-2032F |
6.2.4 Austria Rare Disease Treatment Market Revenues & Volume, By Oncology, 2022-2032F |
6.2.5 Austria Rare Disease Treatment Market Revenues & Volume, By Infectious Diseases, 2022-2032F |
6.2.6 Austria Rare Disease Treatment Market Revenues & Volume, By Cardiovascular Diseases, 2022-2032F |
6.2.7 Austria Rare Disease Treatment Market Revenues & Volume, By Other, 2022-2032F |
6.3 Austria Rare Disease Treatment Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Austria Rare Disease Treatment Market Revenues & Volume, By Oral, 2022-2032F |
6.3.3 Austria Rare Disease Treatment Market Revenues & Volume, By Injection, 2022-2032F |
6.3.4 Austria Rare Disease Treatment Market Revenues & Volume, By Others, 2022-2032F |
7 Austria Rare Disease Treatment Market Import-Export Trade Statistics |
7.1 Austria Rare Disease Treatment Market Export to Major Countries |
7.2 Austria Rare Disease Treatment Market Imports from Major Countries |
8 Austria Rare Disease Treatment Market Key Performance Indicators |
8.1 Number of patients diagnosed with rare diseases annually |
8.2 Research and development investment in rare disease treatments |
8.3 Number of clinical trials conducted for rare disease treatments |
9 Austria Rare Disease Treatment Market - Opportunity Assessment |
9.1 Austria Rare Disease Treatment Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Austria Rare Disease Treatment Market Opportunity Assessment, By Therapeutic Area, 2022 & 2032F |
9.3 Austria Rare Disease Treatment Market Opportunity Assessment, By Administration, 2022 & 2032F |
10 Austria Rare Disease Treatment Market - Competitive Landscape |
10.1 Austria Rare Disease Treatment Market Revenue Share, By Companies, 2025 |
10.2 Austria Rare Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here